PTX3 and obesity due to melanocortin 4 receptor deficiency: Although the majority of available studies indicate a negative impact of obesity on plasma PTX3 in the general population and various disease states [11-18], obesity is a strong risk factor for cardiovascular events and PTX3 is commonly elevated in ACS [7-10].